Skip to main content

Glen Eagle Advisors, LLC

SEC CIK
0002029317
Latest filing
Aug 14, 2026

EW holding history

Edwards Lifesciences Corp in every 13F filed by Glen Eagle Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EW overviewAll 13F holders of EWFull Q2 2026 holdings

Shares (Q2 2026)
393
Value
$35.6K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of EW by Glen Eagle Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026393$35.6K<0.1%−32−7.5%ReducedHolders
Q1 2026425$34.0K<0.1%−108−20.3%ReducedHolders
Q4 2025533$45.4K<0.1%−70−11.6%ReducedHolders
Q3 2025603$46.9K<0.1%−353−36.9%ReducedHolders
Q2 2025956$74.8K<0.1%−1,138−54.3%ReducedHolders
Q1 20252,094$151.8K<0.1%−6,597−75.9%ReducedHolders
Q4 20248,691$643.4K0.1%−4,678−35.0%ReducedHolders
Q3 202413,369$882.2K0.1%−1,056−7.3%ReducedHolders
Q2 202414,425$1.33M0.2%+4,965+52.5%AddedHolders
Q1 20249,460$904.0K0.2%+7,395+358.1%AddedHolders
Q4 20232,065$157.5K<0.1%+1,398+209.6%AddedHolders
Q3 2023667$46.2K<0.1%00.0%UnchangedHolders
Q2 2023667$62.9K<0.1%00.0%UnchangedHolders
Q1 2023667$55.2K<0.1%00.0%UnchangedHolders
Q4 2022667$49.8K<0.1%00.0%UnchangedHolders
Q3 2022667$55.1K<0.1%00.0%UnchangedHolders
Q2 2022667$63.4K<0.1%00.0%UnchangedHolders
Q1 2022667$78.5K<0.1%00.0%UnchangedHolders
Q4 2021667$86.4K<0.1%00.0%UnchangedHolders
Q3 2021667$75.5K<0.1%−23−3.3%ReducedHolders
Q2 2021690$71.5K<0.1%00.0%UnchangedHolders
Q1 2021690$57.7K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.